Computer Aided Design and Grading for an Electronic Functional Programming Exam

Electronic exams (e-exams) have the potential to substantially reduce the effort required for conducting an exam through automation. Yet, care must be taken to sacrifice neither task complexity nor constructive alignment nor grading fairness in favor of automation. To advance automation in the design and fair grading of (functional programming) e-exams, we introduce the following: A novel algorithm to check Proof Puzzles based on finding correct sequences of proof lines that improves fairness compared to an existing, edit distance based algorithm; an open-source static analysis tool to check source code for task relevant features by traversing the abstract syntax tree; a higher-level language and open-source tool to specify regular expressions that makes creating complex regular expressions less error-prone. Our findings are embedded in a complete experience report on transforming a paper exam to an e-exam. We evaluated the resulting e-exam by analyzing the degree of automation in the grading process, asking students for their opinion, and critically reviewing our own experiences. Almost all tasks can be graded automatically at least in part (correct solutions can almost always be detected as such), the students agree that an e-exam is a fitting examination format for the course but are split on how well they can express their thoughts compared to a paper exam, and examiners enjoy a more time-efficient grading process while the point distribution in the exam results was almost exactly the same compared to a paper exam.Comment: In Proceedings TFPIE 2023, arXiv:2308.0611

Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with uncontrolled activation of lymphocytes and macrophages. Besides a primary (genetic) form, HLH can also be triggered by malignant, autoimmune and infectious diseases. HLH recurrences are rarely described, usually only in primary HLH. Parvovirus B19 (PVB19) Infection is one of the rare and rather benign causes of HLH. Since the infection usually results in long-lasting immunity, recurrent viremia is very uncommon. CASE PRESENTATION: We report an unusual case of a young female with recurrent PVB19 infection that led to repeated episodes of HLH. The first episode occurred at the age of 25 years with a three-week history of high fever and nonspecific accompanying symptoms. The diagnosis of HLH was confirmed by HLH-2004 criteria and HScore, PVB19 viremia was detected as underlying cause. Following guideline-based therapy, the patient was symptom-free for one year, before similar symptoms recurred in a milder form. Again, PVB19 was detected and HLH was diagnosed according to HScore. After successful treatment and a nine-month symptom-free interval, a third phase of hyperinflammation with low PVB19 viremia occurred; this time, treatment with a corticosteroid and intravenous immunoglobulin was initiated before the presence of clear diagnostic criteria for HLH. No further events occurred in the following three years. CONCLUSIONS: In the case of our patient, the recurrent viremia triggered three episodes of hyperinflammation, two of which were clearly diagnosed as HLH. To our knowledge, this is the first published case of recurrent HLH due to PVB19 infection. Therefore, the case gives new insights in triggering mechanisms for HLH

People, lakes and seashores : Studies from the Baltic Sea basin and adjacent areas in the early and Mid-Holocene

During the Early and Mid-Holocene significant changes in the ecology and socio-cultural spheres occurred around the Baltic Sea. Because of the underlying climatic changes and thus environmental alterations, the area was the scene for various cultural developments during the period under investigation. In the course of the melting of the glaciers at the end of the last Ice Age, isostatic and eustatic movements caused continual changes to the Baltic Sea basin. Changes in water level, however, affected not only the Early and Mid-Holocene coastlines, but also the whole Baltic Sea drainage system, including large lakes, rivers and watersheds in the hinterland were also dramatically impacted by these ecological changes. Prehistoric people were thus affected by changes in resource availability and reduction or enlargement of their territories, respectively. In order to evaluate the impact of changes in the water and land networks on the environment, resource availability, and human behaviour, and to reconstruct human responses to these changes, we pursue an interdisciplinary approach connecting environmental and archaeological research highlighted through different case studies

Characterization of HIV‐1 drug resistance among patients with failure of second‐line combined antiretroviral therapy in central Ethiopia

Background As a consequence of the improved availability of combined antiretroviral therapy (cART) in resource-limited countries, an emergence of HIV drug resistance (HIVDR) has been observed. We assessed the prevalence and spectrum of HIVDR in patients with failure of second-line cART at two HIV clinics in central Ethiopia. Methods HIV drug resistance was analysed in HIV-1-infected patients with virological failure of second-line cART using the geno2pheno application. Results Among 714 patients receiving second-line cART, 44 (6.2%) fulfilled the criteria for treatment failure and 37 were eligible for study inclusion. Median age was 42 years [interquartile range (IQR): 20-45] and 62.2% were male. At initiation of first-line cART, 23 (62.2%) were WHO stage III, mean CD4 cell count was 170.6 (range: 16-496) cells/mu L and median (IQR) HIV-1 viral load was 30 220 (7963-82 598) copies/mL. Most common second-line cART regimens at the time of failure were tenofovir disoproxil fumarate (TDF)-lamivudine (3TC)-ritonavir-boosted atazanavir (ATV/r) (19/37, 51.4%) and zidovudine (ZDV)-3TC-ATV/r (9/37, 24.3%). Genotypic HIV-1 resistance testing was successful in 35 (94.6%) participants. We found at least one resistance mutation in 80% of patients and 40% carried a protease inhibitor (PI)-associated mutation. Most common mutations were M184V (57.1%), Y188C (25.7%), M46I/L (25.7%) and V82A/M (25.7%). High-level resistance against the PI ATV (10/35, 28.6%) and lopinavir (LPV) (5/35, 14.3%) was reported. As expected, no resistance mutations conferring integrase inhibitor resistance were detected. Conclusions We found a high prevalence of resistance mutations, also against PIs (40%), as the national standard second-line cART components. Resistance testing before switching to second- or third-line cART is warranted